Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-25

Clinical Trial Update: Effect of High Dose Ciclesonide on Asthma Control [Phase 3]

View source ↗

Summary

Phase 3 trial results posted evaluating high-dose inhaled ciclesonide for asthma control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-10-25